Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProtein Degradation and Inhibitors · Neuroblastoma Research and Treatments · Lung Cancer Treatments and Mutations
This is a correction to: Yen-Ting Liu, Yi-Hsing Chen, Chen-Han Chang, Hsiang-Kuang Tony Liang, Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature, Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, https://doi.org/10.1093/noajnl/vdae072
The originally published version of this manuscript has been updated to correct the order of author Yen-Ting Liu’s affiliations.